Brinker Capital Investments, LLC Charles River Laboratories International, Inc. Transaction History
Brinker Capital Investments, LLC
- $5.01 Billion
- Q4 2022
A detailed history of Brinker Capital Investments, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 5,159 shares of CRL stock, worth $1.02 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,159
Previous 5,428
4.96%
Holding current value
$1.02 Million
Previous $1.07 Million
5.15%
% of portfolio
0.02%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$411 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$376 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$270 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...